Hypocalcemia with Immune Checkpoint Inhibitors: The Disparity among Various Reports

Figure 1

Hypocalcemia events in patients receiving pembrolizumab with (a) and without risk factors (b). Y-axis depicts the range of calcium levels. X-axis depicts several values. Before ICPI indicates the range of calcium levels before initiation of ICPI treatment. After ICPI indicates the range of calcium levels after ICPI treatment. Hypocalcemia indicates the low calcium levels noted during and after the treatment. Corrected calcium indicates the calcium levels after correcting the low calcium levels with albumin.

(a)

(b)